Delcath FOCUS-Uveal Melanoma - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with uveal melanoma (started in the eye) that spread to the liver.
What is Involved?
If you join the study, you will:
- Have a physical exam and other tests
- Imaging scans (CT scans and MRI scans)
- Receive the Melphalan/HDS therapy up to 6 times, once every 6-8 weeks with blood work every week
- Have liver scans every 10-14 weeks.